Systemic-onset juvenile idiopathic arthritis

Source: Wikipedia, the free encyclopedia.
Systemic juvenile idiopathic arthritis
Other namesSystemic-onset juvenile rheumatoid arthritis, Still's Disease
SpecialtyPediatrics/rheumatology

Systemic juvenile idiopathic arthritis (or the juvenile onset form of Still's disease[1]) is a type of juvenile idiopathic arthritis (JIA) with extra-articular manifestations like fever and rash apart from arthritis. It was originally called systemic-onset juvenile rheumatoid arthritis or Still's disease.

Predominantly extra-articular manifestations like high

inflammation of the pleura, inflammation of the pericardium, inflammation of the heart's muscular tissue, and inflammation of the peritoneum are also seen.[citation needed] It is sometimes called "juvenile-onset Still's disease" to distinguish it from adult-onset Still's disease. However, there is some evidence that the main difference between two conditions is the age of onset.[2]

Presentation

Systemic JIA is characterized by arthritis, fever, which typically is higher than the low-grade fever associated with polyarticular and a salmon pink rash. It accounts for 10-20% of JIA and affects males and females equally, unlike the other two subtypes of JIA, and affects adolescents. It generally involves both large and small joints. Systemic JIA can be challenging to diagnose because the fever and rash come and go. Fever can occur at the same time every day or twice a day (often in late afternoon or evening) with a spontaneous rapid return to baseline (vs. continuous fever of septic arthritis). The rash often occurs with fever. It is a discrete, salmon-pink macules of different sizes. It migrates to different locations on skin, rarely persisting in one location more than one hour. The rash is commonly seen on trunk and proximal extremities or over pressure areas.[citation needed]

Arthritis is often absent in the first weeks or even 6–8 months into the illness. Systemic JIA may have

internal organ involvement such as hepatosplenomegaly, lymphadenopathy, serositis, hepatitis, or tenosynovitis.[citation needed
]

Cause

The cause is unknown but it's thought to be related to environmental, genetic, and hormonal factors.[citation needed]

A polymorphism in macrophage migration inhibitory factor has been associated with this condition.[3]

Diagnosis

Rheumatoid factor and ANA tests are generally negative in systemic JIA. Lab findings:

]

Treatment

Treatment with either

glucocorticoids, methotrexate, anakinra, or tocilizumab has been examined.[5] Anakinra has been shown to resolve the clinical features of the disease in 87% of patients.[6] It also induces remission in half of corticosteroid-resistant patients.[7] The results of another study were similar, with half of the patients responding to treatment with Anakinra.[8] Canakinumab
, an antibody to
interleukin-1 beta, is indicated for treatment in patients who respond poorly to other treatments.[9]

Prognosis

25% of cases progress to severe destructive arthritis.[10] In the United States, mortality is estimated at 4% [11] and in Europe, mortality is estimated at 21.7%.[12]

History

Still's disease is named after

Sir George Frederic Still (1861–1941).[13][14] It was characterized by EG Bywaters in 1971.[15][16]

References

  1. ^ "Still's Disease". MedicineNet. Retrieved 8 June 2017.
  2. PMID 31769856
    .
  3. .
  4. ^ https://www.tm.mahidol.ac.th/seameo/2017-48-suppl-2/2017-48-supp2-141.pdf [bare URL PDF]
  5. PMID 22290637
    .
  6. .
  7. .
  8. .
  9. ^ http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001109/WC500031680.pdf [bare URL PDF]
  10. PMID 16645998
    .
  11. ^ Hoffman, F. "Background Information". Roche Group Media Relations. http://www.roche.com/med-ra-sjia.pdf.pdf Archived 2016-03-04 at the Wayback Machine
  12. ^ Davies, Rebecca; Southwood, T.; Kearsley-Fleet, L.; Lunt, M.; Hyrich, K. (2015). "Standardized Mortality Rates are Increased in Patients with Severe Juvenile Idiopathic Arthritis". Oxford Journal of Rheumatology. 54 (1): i153.
  13. Who Named It?
  14. ^ G. F. Still. A special form of joint disease met with in children. Doctoral dissertation, Cambridge, 1896.
  15. PMID 5315135
    .
  16. .

External links